RNS
AIM: FIPP
9 December 2022
Frontier IP Group Plc
("Frontier IP" or the "Group")
Result of Annual General Meeting
Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that at its annual general meeting, held earlier today, all resolutions were duly passed with the table below summarising proxy votes received.
|
RESOLUTIONS |
NO OF VOTES FOR |
% OF VOTES CAST (EXCLUDING VOTES WITHELD) |
NO OF VOTES AGAINST |
% OF VOTES CAST (EXCLUDING VOTES WITHELD) |
TOTAL VOTES CAST (EXCLUDING VOTES WITHHELD) |
NO OF VOTES WITHHELD |
|
ORDINARY |
||||||
|
1) To receive the audited consolidated financial statements of the Company and its subsidiaries for the year ended 30 June 2022, together with the reports of the Directors and the Auditor thereon. |
31,762,286 |
100.0% |
0 |
0.0% |
31,762,286 |
0 |
|
2) To approve the report of the Board to the members on directors' remuneration for the year ended 30 June 2022. |
31,746,575 |
100.0% |
4,800 |
0.0% |
31,751,375 |
10,911 |
|
3) To re-appoint James M Fish as a Director of the Company, who retires by rotation and, being eligible, is offering himself for reappointment. |
31,759,602 |
100.0% |
0 |
0.0% |
31,759,602 |
2,684 |
|
4) To re-appoint Campbell Wilson as a Director of the Company, who retires by rotation and, being eligible, is offering himself for reappointment. |
31,759,602 |
100.0% |
0 |
0.0% |
31,759,602 |
2,684 |
|
5) To re-appoint BDO LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which financial statements are laid before shareholders. |
31,757,658 |
100.0% |
4,628 |
0.0% |
31,762,286 |
0 |
|
6) To authorise the Directors to determine the auditor's remuneration. |
31,759,602 |
100.0% |
2,684 |
0.0% |
31,762,286 |
0 |
|
7) To authorise the directors to allot shares. |
28,377,302 |
89.3% |
3,383,534 |
10.7% |
31,760,836 |
1,450 |
|
8) To approve the Frontier IP Group plc Long Term Incentive Plan. |
28,371,240 |
89.4% |
3,376,001 |
10.6% |
31,747,241 |
15,045 |
|
SPECIAL |
||||||
|
9) Authority to disapply pre-emption rights in connection with the allotment and issue of equity securities for cash in relation to (i) share option schemes; (ii) rights issue or similar offer; or (iii) allotment of equity securities up to 5% of the issued share capital. |
28,365,452 |
89.3% |
3,395,384 |
10.7% |
31,760,836 |
1,450 |
|
10) Authority to disapply pre-emption rights to allot equity securities for cash. |
31,745,351 |
99.95% |
15,485 |
0.05% |
31,760,836 |
1,450 |
|
11) Authority to purchase own shares on market. |
27,193,531 |
99.97% |
9,051 |
0.03% |
27,202,582 |
4,559,704 |
Votes which have been cast at the discretion of the Chairman have been counted as votes for the resolutions. Votes Withheld are not votes in law and do not count in the number of votes counted for or against a resolution.
ENQUIRIES
|
Frontier IP Group Plc Neil Crabb, Chief Executive Andrew Johnson, Communications and Investor Relations andrew.johnson@frontierip.co.uk Company website: www.frontierip.co.uk
|
T: 020 3968 7815 neil@frontierip.co.uk M: 07464 546 025 |
|
Allenby Capital Limited (Nominated Adviser) Nick Athanas / George Payne
|
T: 0203 328 5656 |
|
Singer Capital Markets (Broker) Sandy Fraser / Harry Gooden / George Tzimas |
T: 0207 496 3000
|
ABOUT FRONTIER IP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
